Get started
Author

Hicran Anık

Observed names: H. Anık, Hicran Anik
ORCID: 0009-0001-7992-4008
Observed ORCID: 0009-0001-7992-4008
OpenAlex ID: A5093897918
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy
2025 · İrem Öner, Hicran Anık, et al. · Medicina · 9
PDF
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
2024 · Haci Arak, Suna Erkiliç, et al. · Journal of Immunotherapy · 9
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports · 8
PDF
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab
2024 · Hasan Cagri Yildirim, Hicran Anik, et al. · Biomolecules and Biomedicine · 6
PDF
Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancer
2024 · İrem Öner, Alper Türkel, et al. · Future Oncology · 1
PDF
9P The efficacy of HIF-1 alpha expression in the response to first-line standard chemotherapy and bevacizumab treatment in patients diagnosed with metastatic cervical cancer
2024 · H.C. Yildirim, H. Anık, et al. · ESMO Open · 1
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2026 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports
PDF
Real-life efficacy and safety data of lorlatinib treatment in ROS-1–positive advanced non-small cell lung cancer: Turkish Oncology Group (TOG) study.
2025 · Sedat Biter, Ahmet Taner Sümbül, et al. · Journal of Clinical Oncology
Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer
2024 · Alper Türkel, Ilknur Deliktaş Onur, et al. · Annals of Human Genetics
PDF
Works count: 9
Citation count: 34
H-index: 4
I10-index:
Year
Topic
Type